PARABOLIC EBITDA

<div class='circular--portrait' style='background:#FF01C9;color: #FFF8DC;font-size:4em;padding-top: 25px;;'>PD</div>
PARABOLIC DRUGS ebitda fundamental analysis lookup allows you to check this and other indicators for PARABOLIC DRUGS or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search E BI TD A

 
Refresh

PARABOLIC EBITDA Analysis

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Parabolic Drugs Limited develops, manufactures, sells, and exports medicinal chemicals, botanical products, and active pharmaceutical ingredients and intermediates.
EBITDA 
 = 
Revenue 
-  
Basic Expenses 
More About EBITDA | All Equity Analysis

Current PARABOLIC DRUGS EBITDA

(717.55 M)

About EBITDA

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures. Compare to competition
According to company disclosure PARABOLIC DRUGS reported loss before interest,tax, depreciation and amortization of -7.1755E8. This is 181.78% lower than that of the Healthcare sector, and 2587.03% higher than that of Drugs - Generic industry, The EBITDA for all stocks is 118.41% higher than the company.

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

PARABOLIC Fundamentals



 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page